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SL1  Modeling Psychiatric/
Neurological disorders using iPS cell 
technologies and transgenic non-
human primates
Hideyuki Okano
Department of Physiology, Graduate School of Medicine, Keio University, 
Japan
What makes the investigation of human psychiatric/
psychiatric disorders so difficult? In order to overcome 
these difÀ culties, we took advantage of iPS cell technologies 
and transgenic non-human primates for modeling 
human psychiatric/psychiatric disorders. So far, we have 
established iPS cells from the patients of about 30 human 
psychiatric/psychiatric disorders and characterized their 
pathophysiology. For faithfully modeling the human 
psychiatric/psychiatric disorders in vivo, we developed 
transgenic non-human primates (common marmosets) with 
germline transmission (Sasaki et al., Nature, 2009). In 
the present talk, we also wish to mention our recent data 
of generation of common marmoset transgenic models of 
neurodegenrerative diseases, including Parkinson disease, 
Alzheimer disease and ALS. Furthermore, we could 
generate knock-out technologies of common marmoset using 
genome editing technologies for the generation of transgenic 
marmoset model of autism and psychiatric disorders. At the 
end, I will mention about Brain Mapping Projects in Japan, 
in which investigation of common marmoset brains plays 
key roles.
SL3  Perspectives of disease-
modifying therapy for 
neurodegenerative disease
Gen Sobue
Department of Neurology, Nagoya University Graduate School of Medicine, 
Japan
Spinal and bulbar muscular atrophy (SBMA) is an adult-
onset motor neuron disease caused by the expansion of a 
trinucleotide CAG repeat, which encodes the polyglutamine 
tract, within the first exon of the androgen receptor (AR) 
gene. The ligand-dependent accumulation of the pathogenic 
AR, an initial step in the neurodegenerative process in 
SBMA, is followed by several downstream molecular 
events such as transcriptional dysregulation and axonal 
transport disruption. Androgen deprivation through 
leuprorelin improved the symptoms, histopathological 
findings, and nuclear accumulation of the pathogenic AR 
in the male AR-97Q mice. In a large-scale randomized 
clinical trial, leuprorelin treatment was associated with a 
greater reduction in barium residue than was placebo. We 
also identified miR-196a CGRP-1, HSPs, etc, as molecules 
which regulate disease pathophysiology of SBMA, and 
thus these are the target for disease-modifying therapy for 
neurodegenerative diseases.S4SL2  Infl ammation and immune 
mechanisms of brain damage after 
stroke
Christopher G. Sobey
Department of Pharmacology, Monash University, Australia
Stroke accounts for more than 10% of deaths worldwide, 
and over a third of survivors are left with major neurological 
impairment. The need for new and effective therapies for 
stroke is therefore clear and urgent. While some advances 
have been made toward understanding its mechanisms, still 
only one intervention has been found to reduce brain injury 
following clinical stroke - the ‘clot-buster’ recombinant 
tissue plasminogen activator. Unfortunately however, with 
a short time window of only 4.5 h, this therapy is available 
to less than 10% of stroke patients. For further advances 
in the clinical treatment of ischemic stroke, the complex 
mechanisms of cellular injury following cerebral ischemia 
must be elucidated to provide novel targets for future 
therapies. The initial ischemic insult is now known to be 
followed by induction of cytokines and chemokines, which 
attract numerous inflammatory cell types to the damaged 
brain region and ultimately contribute to secondary brain 
injury. Neutrophils, monocytes, T and B lymphocytes may 
each become activated, inÀ ltrate the brain and modulate the 
severity of stroke outcome. This presentation will describe 
some of our recent work targeting various immune cell 
mechanisms for novel therapies in acute stroke.
SL4  Functional analyses of target 
proteins for drug development by NMR
Ichio Shimada
Graduate School of Pharmaceutical Sciences, Th e University of Tokyo, Japan
G-protein coupled receptors (GPCR) and kinases play 
fundamental roles in many physiological processes and also 
are target proteins for drug development. However, it is 
frequently difficult to obtain structural information about 
the membrane protein dynamics related to the functions. 
This is mainly due to the difÀ culties in sample preparation: 
expression and purification of the membrane proteins 
with the biological activities, and lack of appropriate NMR 
strategy. In this paper, we will show our recent results of 
dynamical aspects of GPCR and mitogen-activated protein 
kinases (MAPKs), which are responsible for the biological 
functions.1) Kofuku,Y., et al., Nat. Commun. doi: 10.1038/
ncomms2046 (2012)2) Kofuku,Y., et al., Angew. Chem. Int. 
Ed. Engl. doi: 10.1002/anie.201406603 (2014)3) Tokunaga,Y., 
et al., Nat. Struct. Mol. Biol. 21, 704-11 (2014)4) Takeuchi K., 
et al., Sci. Rep. 4, 6922, (2014)
SL5  Analysis of brain functions 
with pharmacological perspectives
Norio Matsuki
Emeritus Professor of Th e University of Tokyo, Japan
Analysis of the mechanism of drug actions as well as 
comprehension of true nature of drugs are strong points 
of the pharmacology, which cannot be accomplished with 
reductionism. The knowledge between molecular level 
and individual behavior level is still a black box. Broader 
temporal and spatial analysis of neural activities with 
concomitant micro-level resolution reveal novel contrivance 
of brain function. We have found that febrile seizure of 
neonates induces abnormal location of granule cells in the 
hippocampus via upregulation of GABA receptors that 
persists into adulthood. Hippocampal neural activities 
are modified by intra- and extra-hippocampal active 
levels. Complex inter-nuclei interactions are important for 
accomplishment of fear memory in which amygdala plays 
a crucial role. Brain function is not free from peripheral 
activities. Activation of vagus afferents bidirectionally 
affects synaptic activities in the hippocampus as well as 
formation of memory. Personal view of prospective direction 
of pharmacology will be addressed.
SL7  Post-translational regulaiton 
of NF-ȀB signaling at the angle of 
methylation
Gang-Min Hur
Department of Pharmacology, College of Medicine, Chungnam National 
University, Republic of Korea
It has been well established that NF-ƬB activation must be 
kept temporally and spatially in check by well-orchestrated 
negative feedback l oops to protect excessive activation. 
However, in cancer cells, these feedback loops are overridden 
through unclear mechanisms to sustain a constitutive 
activation of NF-ƬB signaling. The topic will be present and 
discuss how we made a novel discovery that tudor domain 
containing protein, PHF20 is a key protein to maintain NF-
ƬB in a default active state. Here, we show that, in PHF20 
overexpressing cells, the termination of TNF-induced p65 
phosphorylation is impaired while the upstream signaling 
events triggered by TNF are not affected. More importantly, 
the involvement of PHF20 in this process is specifically 
and highly contingent upon its interaction with Lys 
methylated-p65 which interrupts the recruitment of protein 
phosphatase PP2A to p65 and thus leads to a prolonged p65 
phosphorylation. Thus, here we propose a new molecular 
mechanism of constitutive NF-ƬB activation by PHF20 
recognizes the methylation status of p65 in the context of 
pathologic conditions such as inflammation-linked cancer 
development.SSL6  The magic of calcium ion 
entry: discovery, disease and drugs
David J. Beech
Faculty of Biological Sciences, University of Leeds, UK
Calcium is important not only for the structure of bone but 
also for signaling in every cell of the body. There is a huge 
concentration gradient into cells and multiple mechanisms 
exist to regulate its entry. Once in the cell calcium 
profoundly inÁ uences many process depending on amplitude, 
space and time. Entry via voltage-gated calcium channels 
often leads to excitation, for example in the form of muscle 
contraction and neurotransmitter release. These channels 
are inhibited by drugs such as amlodipine and pregabalin, 
used to treat hypertension and neurological conditions such 
as neuropathic pain in diabetes. But many other types of 
calcium channel have been discovered over the past 20 
years: gated not by voltage but other factors. They exist also 
in non-excitable cells and many are up-regulated in common 
diseases. We are investigating these other channels which 
include Piezo channels, identiÀ ed 5 years ago as mechanical 
impact sensors in nociceptive neurones. Recently we 
identified importance of Piezo1 as a frictional force sensor 
of endothelial cells, showing its critical role in development 
(Li et al 2014 Nature doi: 10.1038/nature13701). We are now 
developing small-molecule modulators of non-voltage-gated 
calcium-permeable channels to facilitate studies of their 
biology and explore their potential for drug discovery.
SL8  DNA damage responses 
and their potential use as therapeutic 
targets for malignant tumors
Makoto Nakanishi
Department of Cell Biology, Graduate School of Medical Sciences, Nagoya 
City University, Japan
DNA damage responses (DDR) are important surveillance 
systems to maintain genomic integrity. Once genomic 
stresses such as DNA damage, oxidative stress, and 
activation of oncogenes are sensed, DDR execute transient 
cell cycle arrest through inhibition of the activity of 
cell cycle regulators. DDR also trigger apoptosis and 
cellular senescence when cells sense severe and extensive 
chromosomal abnormalities. Numerous key players 
have been identified in terms of damage sensor proteins, 
transducer kinases and effectors, but their coordination, 
interconnectedness, and the mechanisms by which they 
regulate important anti-tumor protective responses have 
become evident only recently. Under genomic stresses, cell 
survival is completely dependent on these mechanisms. 
However, most cancer cells defect a part of DDR, leading to 
gross genomic instability and malignant transformation. 
These observations also indicate that survival of cancer 
cells depends on the residual DDR. Thus, inhibitors for the 
residual DDR might be effective and speciÀ c drugs for most 
cancers through inducing synthetic lethality. In this talk, 
I would like to introduce details of DDR and discuss about 
their potential use as therapeutic targets for malignant 
tumors.5
SL9  Renin angiotensin system 
and cardiovascular diseases
Hiroshi Iwao
Department of Education, Shitennoji University, Japan
Tigerstedt and Bergmann discovered renin in 1898. Recent 
40 years renin-angiotensin research has been rapidly 
promoted in fields of protein chemistry, molecular biology, 
genetically-modified animals, and drug discovery. The 
inhibitors of renin-angiotensin system contribute to the 
therapy in cardiovascular diseases. Short review of these 
À ndings and ongoing topics will be made comments.
Cardiovascular diseases have cross interactions with chronic 
inflammation. In these circumstances exosome play a role 
on cell to cell communications. Exosome contains many 
intracellular components such as DNAs, RNAs, proteins, 
and cytokines. Heat shock proteins and tetoraspanin 
containing exosome react with endothelial cell receptors 
such as toll-like receptor. The relationships between 
exosome derived from macrophage and vascular endothelial 
cells in hypertensive animals may play an important role on 
tissue remodeling in chronic hypertension.SSL10  Store-operated Ca2+ entry
James W. Putney
Laboratory of Signal Transduction, National Institute of Environmental 
Health Sciences - NIH, USA
The concept of capacitative or store-operated calcium entry, 
a process by which the depletion of stored calcium signals 
the opening of plasma membrane calcium channels, has its 
roots in the late 1970’s, and was formalized in 1986. The 
À rst part of this lecture will attempt to summarize some of 
the early experimental work that led to the idea of store-
operated calcium entry, some of the initial proofs for it, 
and major advances and distractions leading ultimately to 
the discovery of the major molecular players, STIM1 and 
Orai1. The second part of the lecture will present À ndings 
from current research in my laboratory focusing on the cell 
biology of store-operated channels, and on the physiological 
roles of these channels by use of genetically modiÀ ed mice. 
We discovered that the major pore-forming subunit of the 
store-operated channel, Orai1, exists in two forms due to 
alternative translation initiation. We have examined the 
function of these two forms of Orai1 in forming classical 
CRAC channels, and in more complex channels involving 
TRPC subunits, and in channels that are not store-operated 
but respond to arachidonic acid. Studies with mice lacking 
Orai1 or with conditional deletion of STIM1 reveal multiple 
roles of store-operated channels including: innate immunity, 
exocrine gland function, bone formation, the differentiation 
and wound-healing function of skin, lactation, and male 
fertility.6
